Literature DB >> 2289993

Clinical use of selective decontamination: the concept.

D van der Waaij1, W L Manson, J P Arends, H G de Vries-Hospers.   

Abstract

Infections can be classified according to: (1) the type of offending microorganism (virus, bacteria, fungi, parasites), (2) according to the clearance by the defence system (T cell dependent/independent) and (3) in case bacteria are the causative agents in Gram-positive and Gram-negative infections. The latter classification in Gram-positive and Gram-negative infections has appeared to have a practical consequence. Gram-negative bacteria, often involved in major infections and yeasts, appear to play practically no role in the intestinal ecological system. Consequently, it is nowadays increasingly attempted to eliminate Gram-negative bacteria and yeasts selectively from the digestive tract with antimicrobial agents. Selective suppression of Gram-positive bacteria may severely affect the ecosystem of the digestive tract. This selective suppression of Gram-negatives must be continued as long as patients are immunocompromised (locally or systemically) and is called selective decontamination of the digestive tract.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2289993     DOI: 10.1007/bf01709703

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  48 in total

1.  Bacterial interference by oropharynegeal and clinical isolates of anaerobic bacteria.

Authors:  P R Murray; J E Rosenblatt
Journal:  J Infect Dis       Date:  1976-09       Impact factor: 5.226

2.  Enzymatic inactivation of aztreonam by faecal enzyme preparations from healthy volunteers.

Authors:  G W Welling; G Groen; S Welling-Wester; H G de Vries-Hospers; D van der Waaij
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

3.  Determination of the colonization resistance of the digestive tract of individual mice.

Authors:  D van der Waaij; J M Berghuis
Journal:  J Hyg (Lond)       Date:  1974-06

Review 4.  Genitourinary infections in the patient at risk: extrinsic risk factors.

Authors:  C M Kunin
Journal:  Am J Med       Date:  1984-05-15       Impact factor: 4.965

5.  Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients.

Authors:  E J Bow; T J Louie; P D Riben; R D McNaughton; G K Harding; A R Ronald
Journal:  Am J Med       Date:  1984-02       Impact factor: 4.965

6.  Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation.

Authors:  T Schmeiser; E Kurrle; R Arnold; D Krieger; W Heit; H Heimpel
Journal:  Infection       Date:  1988       Impact factor: 3.553

7.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

8.  Trimethoprim used for selective decontamination of the digestive tract in rats: possible route of excretion.

Authors:  A G Toorop-Bouma; D van der Waaij
Journal:  Scand J Infect Dis       Date:  1987

9.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Infection by the distribution of biotypes of enterobacteriacease species in leukaemic patients treated under ward conditions and in units for protective isolation in seven hospitals in Europe.

Authors:  D Van der Waaij; T M Tielemans-Speltie; A M De Roeck-Houben
Journal:  Infection       Date:  1977       Impact factor: 3.553

View more
  5 in total

1.  [Epidural and intrathecal administration of alpha 2-adreno-ceptor agonists for postoperative pain relief].

Authors:  M G Rockemann; W Seeling
Journal:  Schmerz       Date:  1996-04-25       Impact factor: 1.107

2.  Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patients.

Authors:  Robin F Benus; Hermie J Harmsen; Gjalt W Welling; Rob Spanjersberg; Jan G Zijlstra; John E Degener; Tjip S van der Werf
Journal:  Intensive Care Med       Date:  2010-03-16       Impact factor: 17.440

Review 3.  Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit.

Authors:  P D Potgieter; J M Hammond
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.

Authors:  Elena Buelow; Teresita D J Bello González; Susana Fuentes; Wouter A A de Steenhuijsen Piters; Leo Lahti; Jumamurat R Bayjanov; Eline A M Majoor; Johanna C Braat; Maaike S M van Mourik; Evelien A N Oostdijk; Rob J L Willems; Marc J M Bonten; Mark W J van Passel; Hauke Smidt; Willem van Schaik
Journal:  Microbiome       Date:  2017-08-14       Impact factor: 14.650

5.  Ventilator-induced lung injury is aggravated by antibiotic mediated microbiota depletion in mice.

Authors:  Sandra-Maria Wienhold; Mario Macrì; Geraldine Nouailles; Kristina Dietert; Corinne Gurtner; Achim D Gruber; Markus M Heimesaat; Jasmin Lienau; Fabian Schumacher; Burkhard Kleuser; Bastian Opitz; Norbert Suttorp; Martin Witzenrath; Holger C Müller-Redetzky
Journal:  Crit Care       Date:  2018-10-29       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.